Cannabis company Xebra Brands Ltd. (CSE:XBRA) (OTC:XBRAF) (FSE: 9YC) reported Thursday it has started formal marijuana cultivation in the Netherlands, including THC varietals.
As 1 of only 5 companies to be selected by the Dutch government to participate in trial medicinal cannabis cultivation, Xebra is seeking to secure 1 of 2 licenses, with a contract for up to 6 years - providing for revenues of up to U$79 million (€70.5 million) - to co-supply all pharma-grade cannabis to be sold in the Netherlands.
Cultivation in the Netherlands is conducted in Xebra's indoor facility. Xebra's specific genetic varieties are characterized by high production, compact flowers of excellent quality and fine-tasting terpene profiles, with a growth cycle of 12-16 weeks.
More recent news from Xebra:
Xebra's Shares Skyrocket On Receiving Trademarks In Mexico For THC And CBD-Infused Beverage Brands
Price Action
Xebra’s shares traded 10.84% lower at 25 cents per share at the time of writing Thursday morning.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
